Case-control study of thromboembolic events associated with IV immunoglobulin

Serious adverse events related to IVIg treatment are unusual, and interventions can be taken to reduce the risk of anaphylaxis, congestive heart failure and renal failure. Stroke and other thromboembolic (TE) events have also been associated with IVIg administration but the risk factors are unknown....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2009-03, Vol.256 (3), p.339-342
Hauptverfasser:	Caress, J. B., Hobson-Webb, L., Passmore, L. V., Finkbiner, A. P., Cartwright, M. S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Aged Aged, 80 and over Anaphylaxis Biological and medical sciences Cardiovascular Diseases - epidemiology Case-Control Studies Confidence Intervals Control charts Female Heart attacks Humans Immunoglobulins Immunoglobulins, Intravenous - adverse effects Male Medical records Medical sciences Medicine Medicine & Public Health Middle Aged Mortality Myocardial Infarction - chemically induced Myocardial Infarction - mortality Neurology Neuroradiology Neurosciences Odds Ratio Original Communication Risk Factors Stroke Stroke - chemically induced Stroke - mortality Thromboembolism Thromboembolism - chemically induced Thromboembolism - mortality Thrombosis Tumors of the nervous system. Phacomatoses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!